You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 247 No. 12, March 26, 1982 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (18)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Rhesus Diploid Rabies Vaccine (Adsorbed), A New Rabies Vaccine

Results of Initial Clinical Studies of Preexposure Vaccination

Byron S. Berlin, MD; John R. Mitchell, DVM; George H. Burgoyne, PhD; Dunlap Oleson, MD; William E. Brown, MD; Claude Goswick, MD; Norman B. McCullough, MD, PhD

JAMA. 1982;247(12):1726-1728.


Abstract

To meet the need for a safe, efficacious, and low-cost rabies vaccination program, the Michigan Department of Public Health developed a new rabies vaccine: rhesus diploid rabies vaccine, adsorbed (RDRV). Initial clinical studies were conducted in 534 volunteers using preexposure protocols consisting of two injections of RDRV given 1, 2, or 4 weeks apart. This new rabies vaccine induced an excellent rabies virus antibody response two to three weeks after vaccination: antibody levels were superior to those reported after duck embryo rabies vaccine and were similar to those reported with human diploid rabies vaccine. In addition, vaccination with RDRV was associated with an acceptable level of local and constitutional symptoms.

(JAMA 1982;247:1726-1728)



Author Affiliations

From the Bureau of Disease Control and Laboratory Services, Michigan Department of Public Health, Lansing (Drs Berlin, Burgoyne, and Mitchell); the Drake Student Health Center, Auburn University, Auburn, Ala (Dr Oleson); the University Health Service, Ohio State University, Columbus (Dr Brown); the A. P. Beutel Health Center, Texas A&M University, College Station (Dr Goswick); and the Department of Medicine, Microbiology, and Public Health, Michigan State University, East Lansing, Mich (Dr McCullough).


Footnotes

Reprint requests to Bureau of Disease Control and Laboratory Services, Michigan Department of Public Health, 3500 N Logan St, Lansing, MI 48909 (Dr Berlin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Rhesus Diploid Rabies Vaccine (Adsorbed), A New Rabies Vaccine: II. Results of Clinical Studies Simulating Prophylactic Therapy for Rabies Exposure
Berlin et al.
JAMA 1983;249:2663-2665.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.